# BioAge Labs, Inc. (BIOA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from BioAge Labs, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BIOA/mda/fy2025/): filed 2026-03-24; accession 0001193125-26-120873 (https://www.sec.gov/Archives/edgar/data/1709941/000119312526120873/bioa-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BIOA/mda/fy2024/): filed 2025-03-20; accession 0000950170-25-042759 (https://www.sec.gov/Archives/edgar/data/1709941/000095017025042759/bioa-20241231.htm)

Back to /company/BIOA/